JNJ
Johnson & Johnson
NEW YORK STOCK EXCHANGE, INC.· Pharmaceuticals· US· IPO 1944-09-25
$266.17
-4.39 (-1.62%)
last quote
Want the full multi-source brief on JNJ?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$266.17
High
$271.07
Low
$265.29
Previous close
$270.56
Fundamentals
Market cap
$650.96B
P/E (TTM)
40.44x
P/S (TTM)
6.55x
P/B
6.13x
Gross margin
67.69%
Operating margin
17.86%
Net margin
16.20%
Rev growth (YoY)
7.80%
EPS growth (YoY)
-36.41%
ROE
25.74%
52W high
$282.01
52W low
$185.12
Beta
0.18x
Industry peers
by market cap
Upcoming earnings
next 30 days
2027-01-26in 82 daysafter market
Q4 2026EPS est $2.94Rev est $26696.6M
Recent SEC filings
CIK 200406filing-language history →
Recent news
2026-10-28 → 2026-11-04
Yahoo · 14h
Should You Buy Baxter Stock For Its Cash?
For questions about this article or underlying research, email help@trefis.com.
Yahoo · 16h
BAYRY Q3 Earnings and Revenues Miss Estimates, Pharma Performs Well
Bayer's Q3 earnings and revenues miss estimates, but strong growth in Nubeqa and Kerendia boosts pharma performance and lifts 2026 EBITDA guidance.
Yahoo · 18h
AbbVie Hit a New High After Earnings. There’s More Upside Left.
AbbVie just logged a 33% gain for the year and raised its guidance again, but the real question is whether Skyrizi and a newly closed pipeline deal can push shares even further past a valuation that already looks stretched.
Yahoo · 20h
What Could Derail Bristol Myers Squibb Stock?
For questions about this article or underlying research, email help@trefis.com.
Yahoo · 21h
Is Intuitive Surgical Stock Worth More Than Its Competitors?
For questions about this article or underlying research, email help@trefis.com.
Yahoo · 21h
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Yahoo · 22h
Why Did Boston Scientific Stock Jump?
For questions about this article or underlying research, email help@trefis.com.
Benzinga · 1d
Jim Cramer Likes This Industrial Stock: ‘It’s Come Down A Great Deal’
Cramer recommends Howmet and J&J, prefers Micron over Western Digital, criticizes Nebius, and favors Lam Research over KLA.
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial